Frontiers in Immunology Submission Process
Frontiers in Immunology's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Associate Professor, Immunology & Infectious Disease
Author context
Specializes in manuscript preparation and peer review strategy for immunology and infectious disease research, with 10+ years evaluating submissions to top-tier journals.
Readiness scan
Before you submit to Frontiers in Immunology, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
How to approach Frontiers in Immunology
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Section selection and submission |
2. Package | Review editor assessment |
3. Cover letter | Collaborative peer review |
4. Final check | Revision period |
Frontiers in Immunology is one of those journals where the submission process cannot be separated from section fit. Authors often think the process is mainly about uploading a complete file and waiting for collaborative review to begin. In practice, the decisive part comes earlier. The editor first has to believe the paper belongs in the right specialty section and is mature enough for that review model.
This guide is about how the process actually works after upload, where papers slow down, and what you should fix before submission if you want the route to peer review to be cleaner.
Quick answer: how the Frontiers in Immunology submission process works
The Frontiers in Immunology submission process usually moves through these stages:
- portal submission and compliance check
- specialty-section assignment and editorial screening
- collaborative peer review
- interactive revision and first major decision
The critical process question is not only whether the science is strong. It is whether the paper is in the correct section, framed for the right audience, and ready for a review style that expects clear scope, reproducibility, and open-science compliance.
That is why papers often run into trouble before reviewers fully engage. The collaborative model works best when the manuscript is already well targeted.
What happens right after upload
Once the manuscript is submitted, the system checks the obvious mechanics:
- files are complete
- metadata and author information are complete
- ethics and data statements are present
- specialty section is selected
- reviewers and editors can be routed appropriately
This journal is especially sensitive to section choice. A paper can be solid and still struggle if it lands in the wrong specialty section because the process then starts from a mismatch.
The first process lesson is simple: Frontiers is not one general immunology gate. It is a network of specialty editorial units. The section decision changes the whole path.
The real editorial screen: what they decide before collaborative review starts
1. Is the section choice correct?
This is probably the biggest process variable in the journal.
Editors need to see that your paper clearly belongs where you submitted it:
- cancer immunology papers should look like cancer papers, not only basic immune signaling
- vaccine or therapeutic papers should show intervention logic, not only descriptive biology
- clinically framed papers should make patient or disease relevance obvious
If the section assignment feels off, the process weakens immediately.
2. Is the manuscript mature enough for collaborative review?
The journal's review model assumes that the paper is close enough to benefit from structured feedback rather than too early for serious peer evaluation.
Editors screen for:
- sufficiently complete methods
- coherent results structure
- reproducible or at least reviewable evidence
- clear framing of why the work matters
A paper that feels too preliminary often slows or stops before the review stage gains momentum.
3. Does the manuscript meet open-science and reporting expectations?
Frontiers cares about data availability, methodology clarity, and reviewable transparency. That does not mean every dataset must be perfect, but vague statements and incomplete reporting create friction fast.
This is especially important for:
- systematic reviews
- meta-analyses
- translational or clinical papers
- large immune profiling studies
If the reporting layer is thin, the process gets harder before the science is even debated.
Where this process usually slows down
The Frontiers path often slows in a few predictable ways.
Section mismatch creates editorial hesitation
If the paper belongs in a different specialty section than the one selected, the editor has to decide whether to reroute, decline, or seek additional judgment. That creates avoidable delay.
The paper looks descriptive instead of decision-useful
Some immunology papers report observations but do not make the disease, therapeutic, or mechanistic consequence clear enough. That makes the editor unsure whether the manuscript is strong enough for the process to continue.
Methodology is not transparent enough
Papers with unclear screening logic, underexplained methods, or soft systematic-review practice often stall because the review model works badly when the methodological base is not easy to inspect.
Reviewer fit is harder than the authors expect
Because the journal spans many sections and subfields, reviewer routing can be tricky when a manuscript sits between mechanistic immunology, translational disease work, and intervention-focused research.
A cleaner process starts before submission
If you want a smoother route, work backwards from what the editor and section team need to see.
Step 1. Confirm the section and journal fit
Use the cluster around this journal before uploading:
- Frontiers in Immunology journal page
- How to Choose the Right Journal for Your Paper
- Desk Rejection: What It Means, Why It Happens, and What to Do Next
If the best section is still unclear, that uncertainty is itself a warning. The process is less forgiving when the routing decision is shaky.
Step 2. Make the title and abstract section-specific
The editor should be able to tell quickly:
- what immunology problem the paper addresses
- what disease or mechanism frame matters
- what section audience should care
Generic “immune response” framing is weaker than a clear disease, pathway, or intervention angle.
Step 3. Build the methods so a section editor can trust them fast
This journal rewards manuscripts where methods are easy to inspect:
- clear cohort or model description
- transparent analysis steps
- explicit inclusion logic
- reproducible evidence chain
If the method section feels improvised, the collaborative review promise becomes much less attractive to the editor.
Step 4. Use the cover letter to explain the section choice
Your cover letter should say not only why the paper matters, but why it belongs in this journal and in this section. That helps the editor avoid ambiguity at the exact moment ambiguity is most dangerous.
Step 5. Treat data and reporting statements as process-critical
For Frontiers, data statements and reporting practice are not paperwork after the real science. They are part of whether the manuscript looks ready for review.
What a strong first-decision path looks like here
The best submissions usually move through a sequence like this:
Stage | What the editor wants to see | What slows the process |
|---|---|---|
Initial review | Correct specialty section and clear immunology framing | Section mismatch or generic framing |
Early editorial pass | Methods and evidence that look review-ready | Thin methodology or soft reporting |
Reviewer routing | Obvious reviewer community and clean scope | Cross-field ambiguity |
First decision | Constructive debate on a well-positioned manuscript | Reviewers arguing about what the paper is supposed to be |
That is why the process can feel smooth for some authors and unexpectedly messy for others. The file has to be easy to route and easy to trust.
What to do if your submission seems stuck
If the paper is sitting without movement, do not jump straight to a negative conclusion. Delay can mean:
- the section routing is still being clarified
- reviewers are still being found
- the editor is deciding whether the manuscript is mature enough for review
The useful response is to look back at the submission package and ask:
- was the section clearly the right one
- was the disease or translational relevance obvious enough
- were the data and methods review-ready on first inspection
Those are the issues most likely to affect this journal's process.
Final checklist before you submit
Before you upload, make sure you can answer yes to these:
- is the specialty section clearly the right one
- does the abstract make the disease, mechanism, or intervention frame obvious
- are the methods transparent enough for a fast editorial trust check
- do the reporting and data statements look complete
- does the cover letter explain why this paper belongs in this journal and section
If the answer is yes, the Frontiers in Immunology submission process is much more likely to become a useful collaborative review rather than an avoidable routing problem.
One final practical point: if you know your paper sits between two specialty sections, resolve that before submission rather than hoping the journal will sort it out for you. In this process, ambiguity is rarely neutral. It usually becomes delay.
- Frontiers in Immunology aims, section descriptions, author guidance, and submission instructions from Frontiers.
- Frontiers reporting, data availability, and editorial process guidance.
- Manusights cluster guidance for Frontiers in Immunology fit, submission, and desk-rejection risk.
Jump to key sections
Final step
Submitting to Frontiers in Immunology?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Submitting to Frontiers in Immunology?
Anthropic Privacy Partner. Zero-retention manuscript processing.